Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

BACKGROUND: Prior economic analysis that compared the 12-gene assay to published patterns of care predicted the assay would improve outcomes while lowering medical costs for stage II, T3, mismatch-repair-proficient (MMR-P) colon cancer patients. This study assessed the validity of those findings wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Steven R., Yu, Tiffany M., Behrens, Robert J., Renfro, Lindsay A., Srivastava, Geetika, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, John P., Kim, George P., Mazurczak, Miroslaw A., Hornberger, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244576/
https://www.ncbi.nlm.nih.gov/pubmed/25154747
http://dx.doi.org/10.1007/s40273-014-0207-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244576/
https://www.ncbi.nlm.nih.gov/pubmed/25154747
http://dx.doi.org/10.1007/s40273-014-0207-1

Ejemplares similares